BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 09, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hematide peginesatide regulatory update

Affymax and partner Takeda said they plan to submit an NDA for Hematide peginesatide to treat anemia in chronic kidney disease (CKD) in dialysis patients in 1H11. The timeline will be finalized following a meeting...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >